Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184274
Max Phase: Preclinical
Molecular Formula: C45H75NO13
Molecular Weight: 838.09
Associated Items:
ID: ALA5184274
Max Phase: Preclinical
Molecular Formula: C45H75NO13
Molecular Weight: 838.09
Associated Items:
Canonical SMILES: CCCCC/C=C\C/C=C\CCCCCCC(=O)N[C@H]1[C@H](OC(=O)CCC(=O)O)O[C@H](CO)[C@@H](OC(=O)CCC(=O)O)[C@@H]1OC(=O)CCCCCCCCCCCCC
Standard InChI: InChI=1S/C45H75NO13/c1-3-5-7-9-11-13-15-16-17-19-20-22-24-26-28-36(48)46-42-44(58-39(53)29-27-25-23-21-18-14-12-10-8-6-4-2)43(57-40(54)32-30-37(49)50)35(34-47)56-45(42)59-41(55)33-31-38(51)52/h11,13,16-17,35,42-45,47H,3-10,12,14-15,18-34H2,1-2H3,(H,46,48)(H,49,50)(H,51,52)/b13-11-,17-16-/t35-,42-,43-,44-,45+/m1/s1
Standard InChI Key: BVQHFTBKQJSLHK-IGUCJQIZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 838.09 | Molecular Weight (Monoisotopic): 837.5238 | AlogP: 8.41 | #Rotatable Bonds: 36 |
Polar Surface Area: 212.06 | Molecular Species: ACID | HBA: 11 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.36 | CX Basic pKa: | CX LogP: 9.54 | CX LogD: 2.90 |
Aromatic Rings: 0 | Heavy Atoms: 59 | QED Weighted: 0.02 | Np Likeness Score: 0.80 |
1. Zhang Y, Liang X, Bao X, Xiao W, Chen G.. (2022) Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective., 235 [PMID:35307617] [10.1016/j.ejmech.2022.114291] |
Source(1):